Literature DB >> 4584486

Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel.

J S Kovach, C G Moertel, A J Schutt, R G Reitemeier, R G Hahn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4584486

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  11 in total

Review 1.  New drugs under clinical evaluation in the United States.

Authors:  S K Carter
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

2.  Drug-induced peripheral neuropathies.

Authors:  A M Arnold; C J Williams
Journal:  Br Med J       Date:  1979-04-07

Review 3.  Cisplatin nephrotoxicity. A review.

Authors:  G Daugaard; U Abildgaard
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Combination chemotherapy of cisplatin and 5-fluorouracil for advanced colorectal adenocarcinoma.

Authors:  N J Petrelli; S Madejewicz; Y Rustum; L Herrera; P J Creaven; J Plager; J Soloman; A Mittelman
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

5.  Prediction of nephrotoxicity induced by cisplatin combination chemotherapy in gastric cancer patients.

Authors:  Hyung Hwan Moon; Kyung Won Seo; Ki Young Yoon; Yeon Myung Shin; Kyung Hyun Choi; Sang Ho Lee
Journal:  World J Gastroenterol       Date:  2011-08-14       Impact factor: 5.742

Review 6.  Renal toxicity and chemotherapy in children with cancer.

Authors:  Antonio Ruggiero; Pietro Ferrara; Giorgio Attinà; Daniela Rizzo; Riccardo Riccardi
Journal:  Br J Clin Pharmacol       Date:  2017-09-20       Impact factor: 4.335

7.  Sequence dependence of the antitumor and toxic effects of 5-fluorouracil and cis-diamminedichloroplatinum combination on primary colon tumors in mice.

Authors:  G Pratesi; L Gianni; C Manzotti; F Zunino
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

8.  Activity of two platinum-linked phosphonic acids against autochthonous rat colorectal cancer as well as in two human colon-cancer cell lines.

Authors:  A Galeano; M R Berger; B K Keppler
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

9.  Statistical design considerations for pilot studies transitioning therapies from the bench to the bedside.

Authors:  Rickey E Carter; Robert F Woolson
Journal:  J Transl Med       Date:  2004-10-28       Impact factor: 5.531

10.  Evaluation of single-agent therapy in human colorectal tumour xenografts.

Authors:  P J Houghton; J A Houghton
Journal:  Br J Cancer       Date:  1978-05       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.